Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : PanAmerican BanCorp (PABN) -- Ignore unavailable to you. Want to Upgrade?

To: ColleenB who wrote (21010)	12/21/1998 5:22:00 PM
From: jdcpa	Read Replies (1) \| Respond to of 43774

Related press release out today from Longport, Inc. concerning the scanner that PanAmerican Bancorp has exclusive marketing and management rights to. Longport Announces Agreement with Mammosource, Inc.; First Time Use of Ultrasound Scanning Technology for Breast Cancer Patients SWARTHMORE, Pa., Dec. 21 /PRNewswire/ -- Longport, Inc. (OTC Bulletin Board: LPTI - news) announced today that it has signed an agreement with Mammosource of Marlton, New Jersey. The goal of this agreement is to establish the commercial viability of the Longport Digital Scanner (LDS) in breast pathology applications. This marks the first step in the long term commitment by Longport, Inc. to support and promote breast wellness. In a related development, Longport, Inc. (LPTI) announced that the company is about to file for pro-market notification (510K) for clearance for commercial distribution of its Longport Digital Scanner (LDS). For further information contact Bonita Weyrauch RN, Clinical Trial Coordinator, at 800-289-6863 or visit Longport's web page at www.longportinc.com.